Learn / NNNN
NASDAQ: NNNN
Anbio Biotechnology (NNNN) stock, explained like you're 5
Anbio Biotechnology trades on the Nasdaq under the ticker NNNN. It is a small cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 671 million dollars.
- Ticker
- NNNN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Size
- Small cap, about 671 million dollars
Is Anbio Biotechnology a small, medium or large cap company?
No. Anbio Biotechnology is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 671 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Anbio Biotechnology makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NNNN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Assessing Anbio Biotechnology (NNNN) Valuation After Strong Recent Share Price Momentum (Simply Wall Street)
- 12 Health Care Stocks Moving In Friday's After Market Session (Benzinga)
- Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up (Seeking Alpha)
- Anbio Biotechnology Revenue Breakdown NASDAQ:NNNN (TradingView)
- Anbio Biotechnology (NNNN) Stock Forecast and Price Target 2026 (MarketBeat)
Follow NNNN in your daily brief
Each trading day at 5 PM ET we post what happened to Anbio Biotechnology and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NNNN
Questions about Anbio Biotechnology stock
What does Anbio Biotechnology do?
Anbio Biotechnology trades on the Nasdaq under the ticker NNNN. It is a small cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 671 million dollars.
What is the ticker symbol for Anbio Biotechnology?
Anbio Biotechnology trades under the ticker NNNN on the Nasdaq.
What is Anbio Biotechnology's market cap?
Anbio Biotechnology is a small cap stock with a market cap of about 671 million dollars.
How does Anbio Biotechnology make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NNNN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NNNN stock every day?
Add NNNN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.